Literature DB >> 23919252

Clinical relevance of the (S)-citalopram-omeprazole interaction in geriatric patients.

Roberto Lozano1, Clara Bibian, Raquel-Maria Quilez, Javier Gil, Yamile Constante, Ernesto Garcia-Arilla.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 23919252      PMCID： PMC4093935          DOI： 10.1111/bcp.12223

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  3 in total

1.  Digitalis administration: an underappreciated but common cause of short QT interval.

Authors:  Tsung O Cheng
Journal:  Circulation       Date:  2004-03-09       Impact factor: 29.690

2.  Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteers.

Authors:  Adriana Rocha; Eduardo B Coelho; Stefânia A Sampaio; Vera L Lanchote
Journal:  Br J Clin Pharmacol       Date:  2010-07       Impact factor: 4.335

3.  Population pharmacokinetics and pharmacodynamics of escitalopram in overdose and the effect of activated charcoal.

Authors:  Freek van Gorp; Stephen Duffull; L Peter Hackett; Geoffrey K Isbister
Journal:  Br J Clin Pharmacol       Date:  2012-03       Impact factor: 4.335
  3 in total
  3 in total

1.  Escitalopram population pharmacokinetics in people living with human immunodeficiency virus and in the psychiatric population: Drug-drug interactions and probability of target attainment.

Authors:  Perrine Courlet; Monia Guidi; Anaïs Glatard; Susana Alves Saldanha; Matthias Cavassini; Thierry Buclin; Catia Marzolini; Chin B Eap; Laurent A Decosterd; Chantal Csajka
Journal:  Br J Clin Pharmacol       Date:  2019-07-07       Impact factor: 4.335

2.  Reduced Effectiveness of Interruptive Drug-Drug Interaction Alerts after Conversion to a Commercial Electronic Health Record.

Authors:  Adam Wright; Skye Aaron; Diane L Seger; Lipika Samal; Gordon D Schiff; David W Bates
Journal:  J Gen Intern Med       Date:  2018-05-15       Impact factor: 5.128

3.  Cardiovascular Outcomes Associated With Clinical Use of Citalopram and Omeprazole: A Nationwide Population-Based Cohort Study.

Authors:  Wen-Tung Wu; Chun-Teng Tsai; Yu-Ching Chou; Po-Ming Ku; Yong-Chen Chen; San-Lin You; Chi-Feng Hung; Chien-An Sun
Journal:  J Am Heart Assoc       Date:  2019-10-04       Impact factor: 5.501
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.